Published in Cancer on October 25, 2013
Effect of Patient Navigation on Breast Cancer Screening Among African American Medicare Beneficiaries: A Randomized Controlled Trial. J Gen Intern Med (2015) 0.96
Evaluating a bilingual patient navigation program for uninsured women with abnormal screening tests for breast and cervical cancer: implications for future navigator research. Am J Public Health (2015) 0.81
Cervical cancer screening: the complex interplay of medical infrastructure, society, and culture. Oncologist (2014) 0.79
Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials. J Oncol Pract (2016) 0.77
Lay health educators increase colorectal cancer screening among Hmong Americans: A cluster randomized controlled trial. Cancer (2016) 0.75
Practical Tips for Establishing Partnerships With Academic Researchers: A Resource Guide for Community-Based Organizations. Prog Community Health Partnersh (2015) 0.75
Training in Patient Navigation: A Review of the Research Literature. Health Promot Pract (2015) 0.75
Impact of Event Scale: a measure of subjective stress. Psychosom Med (1979) 21.82
Multiple imputation using chained equations: Issues and guidance for practice. Stat Med (2010) 17.36
Patient navigation: state of the art or is it science? Cancer (2008) 5.62
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health (2005) 5.25
National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer (2008) 4.64
Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst (2010) 3.16
Is economic evaluation in touch with society's health values? BMJ (2004) 2.61
Patient navigation in breast cancer: a systematic review. Cancer Nurs (2010) 2.30
A national patient navigator training program. Health Promot Pract (2008) 2.17
Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev (2003) 1.95
Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol Biomarkers Prev (2012) 1.76
The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests? Cancer Epidemiol Biomarkers Prev (2012) 1.66
Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomarkers Prev (2012) 1.65
History and principles of patient navigation. Cancer (2011) 1.54
Implementing and measuring the impact of patient navigation at a comprehensive community cancer center. Oncol Nurs Forum (2010) 1.31
Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program. Cancer Epidemiol Biomarkers Prev (2012) 1.29
A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomarkers Prev (2012) 1.28
Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol (2003) 1.28
Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. Cancer Epidemiol Biomarkers Prev (2012) 1.26
Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues. Cancer (2009) 1.24
Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities. Cancer Epidemiol Biomarkers Prev (2012) 1.19
The costs of nurse turnover: part 1: an economic perspective. J Nurs Adm (2004) 1.16
A critical analysis of the largest reported mass fecal occult blood screening program in the United States. Am J Surg (1991) 1.12
Health disparities across the cancer continuum. J Health Care Poor Underserved (2007) 1.08
Follow-up among women with an abnormal mammogram in an HMO: is it complete, timely, and efficient? Am J Manag Care (2000) 1.02
Randomized controlled trial of patient navigation for newly diagnosed cancer patients: effects on quality of life. Cancer Epidemiol Biomarkers Prev (2012) 0.93
Impact of patient navigation from diagnosis to treatment in an urban safety net breast cancer population. J Cancer (2011) 0.91
Establishing common cost measures to evaluate the economic value of patient navigation programs. Cancer (2011) 0.89
Oncology Nursing Society, the Association of Oncology Social Work, and the National Association of Social Workers joint position on the role of oncology nursing and oncology social work in patient navigation. Oncol Nurs Forum (2010) 0.87
Are breast cancer navigation programs cost-effective? Evidence from the Chicago Cancer Navigation Project. Health Policy (2010) 0.86
Optimizing the efficacy of first-line chemotherapy plus bevacizumab in metastatic colorectal cancer: analysis of multiple methods. BioDrugs (2011) 0.86
Will designated patient navigators fix the problem? Oncology nursing in transition. Can Oncol Nurs J (2010) 0.81
Annuitizing the human capital investment costs of health service professionals. Health Econ (1999) 0.80
Do navigators' estimates of navigation intensity predict navigation time for cancer care? J Cancer Educ (2011) 0.79
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
Patient navigation: state of the art or is it science? Cancer (2008) 5.62
Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst (2005) 5.52
Measuring patient-centered communication in patient-physician consultations: theoretical and practical issues. Soc Sci Med (2005) 5.39
Why the nation needs a policy push on patient-centered health care. Health Aff (Millwood) (2010) 5.01
National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer (2008) 4.64
A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. J Natl Cancer Inst (2010) 4.04
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol (2006) 3.53
Pure red-cell aplasia and epoetin therapy. N Engl J Med (2004) 3.49
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol (2005) 3.38
Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med (2008) 3.34
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA (2006) 3.29
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol (2006) 2.92
Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol (2012) 2.72
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer (2006) 2.42
A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genet Med (2010) 2.40
Patient-centered communication and diagnostic testing. Ann Fam Med (2005) 2.37
Comparison of survival outcomes among cancer patients treated in and out of clinical trials. J Natl Cancer Inst (2014) 2.30
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am (2013) 2.29
Mechanisms of cancer-related fatigue. Oncologist (2007) 2.25
Reassessments of ESAs for cancer treatment in the US and Europe. Oncology (Williston Park) (2010) 2.22
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol (2009) 2.16
Health care costs among renal cancer patients using pazopanib and sunitinib. J Manag Care Spec Pharm (2015) 2.15
Validity of the Patient Health Questionnaire 2 (PHQ-2) in identifying major depression in older people. J Am Geriatr Soc (2007) 2.14
Sociodemographics, self-rated health, and mortality in the US. Soc Sci Med (2003) 2.13
Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw (2012) 2.13
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2013) 2.11
Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res (2003) 2.10
Visual hallucinations in an elderly woman: a presentation of Charles Bonnet syndrome? J Am Geriatr Soc (2006) 2.10
The Research on Adverse Drug Events and Reports (RADAR) project. JAMA (2005) 2.08
Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement. J Comp Eff Res (2012) 1.91
Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol (2007) 1.91
Virtual colonoscopy using oral contrast compared with colonoscopy for the detection of patients with colorectal polyps. Gastroenterology (2003) 1.88
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Ann Intern Med (2014) 1.87
Racial disparities in the content of primary care office visits. J Gen Intern Med (2005) 1.87
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization. Cancer Epidemiol Biomarkers Prev (2007) 1.80
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke (2004) 1.78
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med (2007) 1.77
Multi-modality mediastinal staging for lung cancer among medicare beneficiaries. J Thorac Oncol (2009) 1.76
Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology (2004) 1.71
Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst (2006) 1.70
Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics. Med Decis Making (2013) 1.70
The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med (2007) 1.68
Design, implementation, and first-year outcomes of a value-based drug formulary. J Manag Care Spec Pharm (2015) 1.67
The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests? Cancer Epidemiol Biomarkers Prev (2012) 1.66
A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract (2012) 1.63
The costs of treating breast cancer in the US: a synthesis of published evidence. Pharmacoeconomics (2009) 1.56
Patients' experiences with navigation for cancer care. Patient Educ Couns (2009) 1.55
Personality, socioeconomic status, and all-cause mortality in the United States. Am J Epidemiol (2009) 1.53
Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine (2009) 1.53
Understanding the processes of patient navigation to reduce disparities in cancer care: perspectives of trained navigators from the field. J Cancer Educ (2011) 1.51
Lessons learned from community-based cancer screening intervention research. Cancer (2004) 1.51
Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer. J Clin Oncol (2012) 1.49
Preventive care. J Gen Intern Med (2004) 1.49
Interpreting measures of treatment effect in cancer clinical trials. Oncologist (2002) 1.49
Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07. J Clin Oncol (2010) 1.47
Structural and reliability analysis of a patient satisfaction with cancer-related care measure: a multisite patient navigation research program study. Cancer (2010) 1.47
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer. J Natl Cancer Inst (2010) 1.44
Racial differences in colorectal cancer screening practices and knowledge within a low-income population. Cancer (2008) 1.42
Breast cancer in pregnancy: a literature review. Arch Surg (2003) 1.41
A logic model for community engagement within the Clinical and Translational Science Awards consortium: can we measure what we model? Acad Med (2013) 1.41
Protection of racial/ethnic minority populations during an influenza pandemic. Am J Public Health (2009) 1.40
Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer (2010) 1.39
Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin Cancer Res (2010) 1.38
Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Med Care (2007) 1.38
Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B. J Natl Cancer Inst (2002) 1.37
Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of gamma-H2AX. Carcinogenesis (2004) 1.37
Breast cancer in limited-resource countries: health care systems and public policy. Breast J (2006) 1.35
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med (2007) 1.34
Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer (2005) 1.33
Can the influence of childhood socioeconomic status on men's and women's adult body mass be explained by adult socioeconomic status or personality? Findings from a national sample. Health Psychol (2009) 1.32
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet Med (2012) 1.32
Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist (2007) 1.32
The relative health burden of selected social and behavioral risk factors in the United States: implications for policy. Am J Public Health (2009) 1.31
Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization. Med Care (2005) 1.31
Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas. J Minim Invasive Gynecol (2005) 1.30
Economic burden for informal caregivers of lung and colorectal cancer patients. Oncologist (2010) 1.30
Patient navigation for breast and colorectal cancer treatment: a randomized trial. Cancer Epidemiol Biomarkers Prev (2012) 1.29
Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B. J Clin Oncol (2005) 1.29
Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion (2004) 1.29
Physician perspectives on incentives to participate in practice-based research: a greater rochester practice-based research network (GR-PBRN) study. J Am Board Fam Med (2010) 1.28
Gene expression profiling and breast cancer care: what are the potential benefits and policy implications? Genet Med (2005) 1.27
Physicians' responses to patients' medically unexplained symptoms. Psychosom Med (2006) 1.27
Elevated sleep disturbance among blacks in an urban family medicine practice. J Am Board Fam Med (2011) 1.27
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol (2005) 1.27
Study protocol: a randomized controlled trial of patient navigation-activation to reduce cancer health disparities. BMC Cancer (2010) 1.26
Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. Cancer Epidemiol Biomarkers Prev (2012) 1.26
Knowledge and beliefs about health promotion and preventive health care among somali women in the United States. Health Care Women Int (2007) 1.26
Effect of patient socioeconomic status on physician profiles for prevention, disease management, and diagnostic testing costs. Med Care (2002) 1.25
Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues. Cancer (2009) 1.24